426 related articles for article (PubMed ID: 31057542)
41. Multiple changes in sialic acid biology during human evolution.
Varki A
Glycoconj J; 2009 Apr; 26(3):231-45. PubMed ID: 18777136
[TBL] [Abstract][Full Text] [Related]
42. Are humans prone to autoimmunity? Implications from evolutionary changes in hominin sialic acid biology.
Varki A
J Autoimmun; 2017 Sep; 83():134-142. PubMed ID: 28755952
[TBL] [Abstract][Full Text] [Related]
43. Biomimetic Glyconanoparticle Vaccine for Cancer Immunotherapy.
Reuven EM; Leviatan Ben-Arye S; Yu H; Duchi R; Perota A; Conchon S; Bachar Abramovitch S; Soulillou JP; Galli C; Chen X; Padler-Karavani V
ACS Nano; 2019 Mar; 13(3):2936-2947. PubMed ID: 30840433
[TBL] [Abstract][Full Text] [Related]
44. Production and Purification of Secretory Simian Cytidine Monophosphate-N-acetylneuraminic Acid Hydroxylase Using Baculovirus-Protein Expression System.
Takahashi T; Kawagishi S; Funahashi H; Hayashi N; Suzuki T
Biol Pharm Bull; 2015; 38(8):1220-6. PubMed ID: 26235586
[TBL] [Abstract][Full Text] [Related]
45. Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid.
Yehuda S; Padler-Karavani V
Front Immunol; 2020; 11():21. PubMed ID: 32038661
[TBL] [Abstract][Full Text] [Related]
46. Glycans in immune recognition and response.
Amon R; Reuven EM; Leviatan Ben-Arye S; Padler-Karavani V
Carbohydr Res; 2014 May; 389():115-22. PubMed ID: 24680512
[TBL] [Abstract][Full Text] [Related]
47. Human CMP-N-acetylneuraminic acid hydroxylase is a novel stem cell marker linked to stem cell-specific mechanisms.
Nystedt J; Anderson H; Hirvonen T; Impola U; Jaatinen T; Heiskanen A; Blomqvist M; Satomaa T; Natunen J; Saarinen J; Lehenkari P; Valmu L; Laine J
Stem Cells; 2010 Feb; 28(2):258-67. PubMed ID: 19890979
[TBL] [Abstract][Full Text] [Related]
48. Gut bacteria responding to dietary change encode sialidases that exhibit preference for red meat-associated carbohydrates.
Zaramela LS; Martino C; Alisson-Silva F; Rees SD; Diaz SL; Chuzel L; Ganatra MB; Taron CH; Secrest P; Zuñiga C; Huang J; Siegel D; Chang G; Varki A; Zengler K
Nat Microbiol; 2019 Dec; 4(12):2082-2089. PubMed ID: 31548686
[TBL] [Abstract][Full Text] [Related]
49. Wild and domestic animals variably display Neu5Ac and Neu5Gc sialic acids.
Nemanichvili N; Spruit CM; Berends AJ; Gröne A; Rijks JM; Verheije MH; de Vries RP
Glycobiology; 2022 Aug; 32(9):791-802. PubMed ID: 35648131
[TBL] [Abstract][Full Text] [Related]
50. N-glycolylneuraminic acid deficiency in humans.
Varki A
Biochimie; 2001 Jul; 83(7):615-22. PubMed ID: 11522390
[TBL] [Abstract][Full Text] [Related]
51. Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells.
Bardor M; Nguyen DH; Diaz S; Varki A
J Biol Chem; 2005 Feb; 280(6):4228-37. PubMed ID: 15557321
[TBL] [Abstract][Full Text] [Related]
52. Human risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acid.
Alisson-Silva F; Kawanishi K; Varki A
Mol Aspects Med; 2016 Oct; 51():16-30. PubMed ID: 27421909
[TBL] [Abstract][Full Text] [Related]
53. N-glycolylneuraminic acid as a carbohydrate cancer biomarker.
Wang J; Shewell LK; Day CJ; Jennings MP
Transl Oncol; 2023 May; 31():101643. PubMed ID: 36805917
[TBL] [Abstract][Full Text] [Related]
54. Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid.
Tangvoranuntakul P; Gagneux P; Diaz S; Bardor M; Varki N; Varki A; Muchmore E
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12045-50. PubMed ID: 14523234
[TBL] [Abstract][Full Text] [Related]
55. Functional evaluation of activation-dependent alterations in the sialoglycan composition of T cells.
Naito-Matsui Y; Takada S; Kano Y; Iyoda T; Sugai M; Shimizu A; Inaba K; Nitschke L; Tsubata T; Oka S; Kozutsumi Y; Takematsu H
J Biol Chem; 2014 Jan; 289(3):1564-79. PubMed ID: 24297165
[TBL] [Abstract][Full Text] [Related]
56. Metabolism of vertebrate amino sugars with N-glycolyl groups: incorporation of N-glycolylhexosamines into mammalian glycans by feeding N-glycolylgalactosamine.
Bergfeld AK; Pearce OM; Diaz SL; Lawrence R; Vocadlo DJ; Choudhury B; Esko JD; Varki A
J Biol Chem; 2012 Aug; 287(34):28898-916. PubMed ID: 22692203
[TBL] [Abstract][Full Text] [Related]
57. Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells.
Dorvignit D; Boligan KF; Relova-Hernández E; Clavell M; López A; Labrada M; Simon HU; López-Requena A; Mesa C; von Gunten S
Sci Rep; 2019 Jul; 9(1):9921. PubMed ID: 31289278
[TBL] [Abstract][Full Text] [Related]
58. Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation.
Ghaderi D; Zhang M; Hurtado-Ziola N; Varki A
Biotechnol Genet Eng Rev; 2012; 28():147-75. PubMed ID: 22616486
[TBL] [Abstract][Full Text] [Related]
59. Characterization of immunogenic Neu5Gc in bioprosthetic heart valves.
Reuven EM; Leviatan Ben-Arye S; Marshanski T; Breimer ME; Yu H; Fellah-Hebia I; Roussel JC; Costa C; Galiñanes M; Mañez R; Le Tourneau T; Soulillou JP; Cozzi E; Chen X; Padler-Karavani V
Xenotransplantation; 2016 Sep; 23(5):381-92. PubMed ID: 27610947
[TBL] [Abstract][Full Text] [Related]
60. Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin.
Byres E; Paton AW; Paton JC; Löfling JC; Smith DF; Wilce MC; Talbot UM; Chong DC; Yu H; Huang S; Chen X; Varki NM; Varki A; Rossjohn J; Beddoe T
Nature; 2008 Dec; 456(7222):648-52. PubMed ID: 18971931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
